Differential inhibition of inflammatory cytokine release from cultured alveolar macrophages from smokers and non smokers by No2

Abstract

Human alveolar macrophages (AMs) obtained from smokers and non-smokers by bronchoalveolar lavage (BAL) were subjected to various concentrations of NO₂ in an inverted monolayer exposure model. Culture super natants were collected 4 h after the exposure and assayed for secreted TNF-α, IL-1β, IL-8 and MIP-1α. The steady state levels of the mRNAs for these cytokines were also analysed in the cells. The adherence of BAL cells to plastic prior to exposure to the gas elevated the steady state mRNA levels of all four cytokines tested in smoker's cells and that of TNF-α and IL-1β, but not IL-8 (MIP-1α not tested), in non-smoker's cells. Interestingly, adherent cells from non-smokers released circa 15-, 3-,1.5- and 3-fold the amounts of IL-1β, IL-8, TNF-α and MIP-1α, respectively, than smoker's cells during control incubation or exposure to air. A 20 min exposure to NO₂ (5 or 20 p.p.m.) did not increase the secretion of any of the cytokines from either cell type. In contrast, NO₂ caused a concentration- dependent inhibition of the secretion of all cytokines except IL-1β from smoker's cells. Additionally, NO₂ greatly diminished the release of all cytokines in response to further treatment with lipopolysaccharide (LPS). In contrast, only the secretion of TNF-α from non-smoker's cells was inhibited by the gas in a concentration- dependent manner, whilst LPS-induced secretion of the cytokines was not affected by the gas. The steady state levels of the respective mRNAs for each of the cytokines were not significantly affected in smoker's cells by exposure to NO₂, except for a negative, dose-dependent trend in the case of TNF-α. Nitrogen dioxide also failed to elevate the levels of the mRNAs in non-smoker's cells but, again, tended to diminish the levels, particularly of IL-1β mRNA. However, exposure to the gas inhibited LPS- induced accumulation of cytokine mRNAs in smoker's cells only. The data suggest that macrophage-derived cytokine mediators of the sepsis response may not play a role in the generation of NO₂-induced inflammation in the human lung. Conversely, the gas seems to non-specifically inhibit the release and/or production of cytokines, particularly from smoker's cells, at the post-transcrip tional level, and impairs the ability of the cells to increase the transcription and release of the cytokines in response to bacterial LPS. The fact that NO₂ seriously impaired the already diminished capacity of smoker's cells to release several important pro-inflammatory cytokines, both under control conditions and in response to LPS, strongly suggest that the inhalation of NO₂ in cigarette smoke may contribute to impairing host defence against infection in the lung.

Keywords

nitrogen dioxide alveolar macrophage cytokine release gene-expression smoking

Get full access to this article

View all access options for this article.

References

Sandström T. , Andersson M-C. , Kolmodin-Hedman B. , Stjernberg N. , Angström T. Bronchoalveolar mastocytosis and lymphocytosis after nitrogen dioxide exposure in man: a time kinetic study. Eur. Respir. J. 1990; 3: 138-143.

Helliday R. , Sandsröm T. , Stjernberg N. Difference in bronchoalveolar cell response to nitrogen dioxide exposure between smokers and non-smokers. Eur. Respir. J. 1994 ; 7: 1213-1220.

Sandström T. Respiratory effects of air pollutants. Experimental studies in humans. Eur. Respir. J. 1995; 8: 976-995.

Nathan CF Secretory products of macrophages. J. Clin. Invest. 1987; 79: 319-326.

Pérez-Arellano JL , Alcázar-Montero MC , Jiménez-López A. Alveolar macrophage: Origin, kinetics and relationship with cells of the alveolointerstitial region. Allergol. Immunopathol. 1990; 18: 175 -183.

Crystal RG Alveolar macrophages. In: The Lung: Scientific Foundations . GR Crystal , JB West et al., (ed) Raven Press, Ltd: New York. pp. 527-538, 1991.

Frampton MW et al. Nitrogen dioxide exposure in vivo and human alveolar macrophage inactivation of influenza virus in vitro. Environ. Res. 1989; 48: 179-192.

McCrea KA et al. Altered cytokine regulation in the lung of cigarette smokers . Am. J. Respir. Crit. Care Med. 1994; 150: 696-703.

Pratt SA , Smith MH , Ladman AJ , Finley TN The ultrastructure of alveolar macrophages from human cigarette smokers and non-smokers. Lab. Invest. 1971; 24: 331-338.

10.

Hoidal JR et al. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am. Rev. Respir. Dis. 1981; 123: 85-89.

11.

Fels Ads , Cohn ZA The alveolar macrophage. J. Appl. Physiol. 1986; 60: 353-369.

12.

Sibille Y. , Reynolds HY Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 1990; 141: 471-501.

13.

Martinet Y. , Yamauchi K. , Crystal RG Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phabocytes. Am. Rev. Respir. Dis. 1988; 138: 659-665.

14.

Koretzky GA et al. Spontaneous production of interleukin-1 by human alveolar macrophages. Clin. Immunol. Immunopathol. 1983; 29: 443-450.

15.

Bevilacqua MP et al. Interleukin-1 acts of cultured human vascular endothelium to increase the adherence of polymorphonuclear leukocytes, monocytes and related cell lines. J. Clin. Invest. 1985; 76: 2003-2011.

16.

Gamble JR , Harlan JM , Klebanoff SJ , Vadas MA Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 1985; 82: 8667-8671.

17.

Strieter RM et al. Human alveolar macrophage gene expresion of interleukin-8 by tumor necrosis factor-α, lipopolysaccharide, and interleukin-1β . Am. J. Respir. Cell Mol. Biol. 1990; 2: 321-326.

18.

Standiford TJ et al. Gene expression of macrophage inflammatory protein-1a from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am. J. Respir. Cell Mol. Biol. 1993; 9: 192-198.

19.

Tu B. , Wallin A. , Moldéus P. , Cotgreave I. Direct exposure to nitrogen dioxide fails to induce the expression of some inflammatory cytokines in an IC-21 murine macrophage cell model. Toxicology 1995; 105: 159-164.

20.

Thomassen MJ et al. Human alveolar macrophage function: differences between smokers and nonsmokers. J. Leukocyte Biol . 1988; 44: 313-318.

21.

Wieslander et al. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors. Eur. J. Respir. Dis. 1987; 71: 263-272.

22.

Brown GP , Iwamoto GK , Monick MM , Hunninghake GW Cigarette smoking decrease interleukin-1 release by human alveolar macrophages . Am. J. Physiol. 1989; 256: C260-C264.

23.

Yamaguchi E. et al. Interleukin-1 production by alveolar macrophages is decreased in smokers. Am. Rev. Respir. Dis. 1989; 140: 397-402.

24.

Sauty A. , Mauel J. , Philippeaux M-M. , Leuenberger P. Cytostatic activity of alveolar macrophages from smokers and non-smokers: role of interleukin-1β, interleukin-6, and tumor necrosis factor-α. Am. J. Respir. Cell. Mol. Biol. 1994; 11: 631-637.

25.

Soliman DM , Twigg III HL Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am. J. Physiol. 1992; 263 (Lung Cell. Mol. Physiol. 7): L471-L478.

26.

Higashimoto Y. et al. Inhibition of mouse alveolar macrophage production of tumor necrosis factor alpha by acute in vivo and in vitro exposure to tobacco smoke. Respiration 1992; 59: 77-80.

27.

Nagai S. et al. Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects. Chest 1988 ; 94: 694-700.

28.

Renoux M. , Lemarié E. , Renoux G. Interleukin-1 secretion by lipopolysaccharide-stimulated alveolar macrophages . Respiration 1989; 55: 158-168.

29.

Mayorga MA Overview of nitrogen dioxide effects on the lung with emphasis on military relevance. Toxicology 1994; 89: 175-192.

30.

Sköld CM , Hed J. and Eklund A. Smoking cessation rapidly reduces cell recovery in bronchoalveolar lavage fluid, while alveolar macrophage fluorescence remains high. Chest 1992; 101: 989-959.

31.

Tu B. , Wallin A. , Moldéus P. , Cotgreave IA Cytotoxicity of NO2 gas to cultured human and murine cells in an inverted monolayer exposure system. Toxicology 1995; 96: 7-18.

32.

Chomczynski P. , Sacchi N.

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical

Biochem. 1987; 162: 56-159.

33.

Price T. , Aitken J. , Simpson ER Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification . J. Clin. Endocrinol. Metab., 1992; 74: 879-883.

34.

Siebert PD , Larrick JW PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. BioTechniques, 1993; 14: 244-249.

35.

Kayama F. , Yoshida T. , Elwell MR , Luster MI Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity . Toxicol. Appl. Pharmacol., 1995; 131: 224-234.

36.

Standiford TJ et al. Interleukin-8 gene expression from human alveolar macrophages: the role of adherence. Am. J. Respir. Cell Mol. Biol. 1991; 5: 579-585.

37.

Strieter RM et al. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-α, lipopolysaccharide, and interleukin-1β . Am. J. Respir. Cell Mol. Biol. 1990; 2: 321-326.

38.

39.

Thomassen MJ et al. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am. J. Respir. Cell Mol. Biol. 1994; 10: 399-404.

40.

Scheule PK , Perkins RC , Hamilton R. , Holian A. 1992. Bleomycin stimulation of cytokine secretion by the human alveolar macrophages. Am. J. Physiol. 1992 ; 262 (Lung Cell Mol. Physiol. 6): L386-L391.

41.

Holt PG Immune and inflammatory function in cigarette smokers. Thorax. 1987; 42: 241-249.